CONTACT-03: Randomized, open-label phase III study of atezolizumab plus cabozantinib versus cabozantinib monotherapy following progression on/after immune checkpoint inhibitor (ICI) treatment in patients with advanced/metastatic renal cell carcinoma Meeting Abstract
| Authors: | Pal, S. K.; Albiges, L.; Rodriguez, C. S.; Liu, B.; Doss, J.; Khurana, S.; Scheffold, C.; Voss, M. H.; Choueiri, T. K. |
| Abstract Title: | CONTACT-03: Randomized, open-label phase III study of atezolizumab plus cabozantinib versus cabozantinib monotherapy following progression on/after immune checkpoint inhibitor (ICI) treatment in patients with advanced/metastatic renal cell carcinoma |
| Meeting Title: | 2021 Genitourinary Cancers Symposium |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 39 |
| Issue: | 6 Suppl. |
| Meeting Dates: | 2021 Feb 11-13 |
| Meeting Location: | Virtual |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2021-02-20 |
| Language: | English |
| ACCESSION: | WOS:000636801500035 |
| DOI: | 10.1200/JCO.2021.39.6_suppl.TPS370 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: TPS370 -- Source: Wos |
